BM Group was founded on a single observation: most equity research is written to be sold, not to be right. We sell nothing else. No banking, no asset management, no advisory fees tied to deal flow. The forward outlook is the product. Its accuracy is our only marketing.
Every 10-K, 10-Q, 8-K, proxy, and S-1 since the company's public listing — read by a human, not parsed by a model.
Plant tours, distributor calls, ex-employee interviews, customer references. The things that don't show up in the filings.
Every projection ships with the variable that, if it moves 10%, breaks the thesis. We tell you what to watch.
Zero investment banking. Zero soft-dollar arrangements. Analyst compensation tied only to the multi-year accuracy of published views.
“We started BM Group because we wanted to read research we could trust. There wasn't any. So we wrote it ourselves, and people kept asking for copies.”